| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8544139 | Thérapie | 2018 | 9 Pages |
Abstract
This study confirms that first trimester exposure to azathioprine is not associated with an elevated rate of birth defects and that the high rate of preterm births among women exposed to azathioprine is probably explained by the underlying maternal disease.
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacology, Toxicology and Pharmaceutics (General)
Authors
Zayneb Alami, Marie Sara Agier, Samir Ahid, Thierry Vial, Anne Dautriche, Laurence Lagarce, Annick Toutain, Yahia Cherrah, Annie-Pierre Jonville-Bera,